PATENT CLAIM ANALYSIS

Application Number: 16178865
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "487000"]

Abstract:
The present invention provides a simple and improved dosage form that is capable of providing a controlled release of GABA B  receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABA B  receptor agonist.

Claim (Index 28):
A controlled release dosage form comprising:\n a) a core comprising: i) 2.5-50 mg of arbaclofen (ARBAC); ii) water swellable polyalkylene oxide poly mer having a molecular weight of about 1,000,000 or less; iii) at least one osmotic salt; iv) at least one binder; and v) water-swellable cellulose derivative polymer selected from hydroxy alkyl alkylcellulose derivative, hydroxyalkylcellulose derivative, or a combination thereof; and b) semipermeable membrane surrounding the core comprising at least one film-forming cellulose ester, and plasticizer.

Metadata:
- Claim Count in Document: 101.0
- Percentile: 98.0
- Lexical Diversity: 1.47222
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15673781', '15680434', '15048743', '15919422', '15919436']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8247632027483779
- 35 USC 102 Novelty (BERT): 0.6180205516381723
- Combined Prediction Score: 0.8040889376373573
- Mean Citation Score: 562.2168720000002
- Max Citation Score: 573.3431
- Similarity Product: 505.8676338269294

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test